Article ID Journal Published Year Pages File Type
3193348 Annals of Allergy, Asthma & Immunology 2007 4 Pages PDF
Abstract
Etoricoxib, like other cyclooxygenase-2 inhibitors, is a well-tolerated drug in most NSAID-sensitive patients. However, according to our experience, a previous challenge test in a safe environment may be necessary before prescribing the drug to such patients.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, , , , , , ,